hyaluronidase (human recombinant) (hylenex) Report issue

Active Ingredient History

  • Now
Hyaluronidases are a family of enzymes that catalyse the degradation of hyaluronic acid (HA). Karl Meyer classified these enzymes in 1971, into three distinct groups, a scheme based on the enzyme reaction products. The three main types of hyaluronidases are two classes of eukaryotic endoglycosidase hydrolases and a prokaryotic lyase-type of glycosidase.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$38.7850 - $46.6925
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

( hyaluronidase (human recombinant) (hylenex), daratumumab (darzalex) - other name: daratumumab and hyaluronidase-fihj )
( hyaluronidase (human recombinant) (hylenex), trastuzumab (herceptin) - other name: trastuzumab and hyaluronidase-oysk )
( hyaluronidase (human recombinant) (hylenex), trastuzumab (herceptin), pertuzumab (perjeta) - other name: pertuzumab, trastuzumab, and hyaluronidase-zzxf )
( hyaluronidase (human recombinant) (hylenex), rituximab (rituxan) - other name: rituximab and hyaluronidase human )
cumulase | human hyaluronidase | hyaluronidase, human | hyaluronidase (human recombinant) | hyaluronidase human recombinant | hyaluronidase recombinant human | hylenex | hylenex recombinant | pegylated recombinant human hyaluronidase | recombinant human hyaluronidase | rhuph20 | vorhyaluronidase alfa


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue